PHARMACY

Novartis, Cytos terminate licensing agreement for smoking-cessation drug

BY Alaric DeArment

SCHLIEREN, Switzerland — Cytos Biotechnology will regain rights to an experimental vaccine against nicotine addiction that it had licensed to Novartis, Cytos said Wednesday.

The company said that Novartis would discontinue the project, known as NIC002. Cytos granted Novartis a license for NIC002 in 2007, but phase-2 trial results in October 2009 indicated that the vaccine spurred the development of nicotine-specific antibodies in patients, but did not increase smoking cessation.

The companies will continue collaborating on the development of CAD106, a treatment for patients with Alzheimer’s disease.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

New ad promotes independents’ agenda in Washington

BY Alaric DeArment

ALEXANDRIA, Va. — A lobbying organization for independent pharmacies has launched an ad campaign in The Hill, the Washington-based daily newspaper covering Congress.

The National Community Pharmacists Association ad lays out the group’s legislative agenda for the 113th Congress and the Obama administration.

This includes calls to impose stronger regulations on pharmacy benefit managers, expand the range of healthcare services pharmacists can provide to alleviate the country’s primary care physician shortage, ensure patients retain access to medications prepared by traditional compounding pharmacies and allow patients to choose the pharmacy of their choice under government health plans.

The group also plans to have its 45th annual NCPA Conference on National Legislation and Government Affairs in May.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

SoloHealth joins former president’s health initiative

BY Alaric DeArment

ATLANTA — Health kiosk maker SoloHealth has joined a health program led by former president Bill Clinton, the company said Wednesday.

The company announced that it had joined the William J. Clinton Foundation’s 2013 Clinton Health Matters Initiative, along with such other companies as General Electric, Humana and Tenet Healthcare. The goal of the CHMI is to improve the health and well-being of people across the country by encouraging individuals, communities and organizations to make meaningful contributions to the health of others. For its part, SoloHealth will build and distribute a tobacco-cessation education module across its SoloHealth Station kiosks, which are placed in thousands of retail locations around the country.

SoloHealth founder and CEO Bart Foster stands next to former president Bill Clinton. SoloHealth announced Wednesday that it would join the William J. Clinton Foundation’s 2013 Clinton Health Matters Initiative.

"We are absolutely thrilled and honored to work with President Clinton and his foundation for this noble and inspiring initiative," SoloHealth CEO Bart Foster said. "As leaders in the healthcare space, we have the responsibility to tackle the issues that lead toward making our world healthier. We look forward to rolling out our smoking-cessation program and our ongoing efforts with the foundation and its Clinton Health Matters Initiative."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES